Clinical, Histopathological, and Prognostic Characteristics of Patients with Prostate Cancer in Lubumbashi, Democratic Republic of Congo

Figure 4

Three-year overall survival by PSA (at diagnosis) group of the patients. Patients with PSA >100 ng/ml show a relatively increased risk of dying compared to those with PSA ≤100 ng/ml.